These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26902195)

  • 1. [Atypical MRI appearance of hepatic focal nodular hyperplasia].
    Tang YH; Zhang F; Wang HY; Kang SH; Zhang XJ; Wang Y; Li J; Ye HY
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):544-6. PubMed ID: 26902195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
    Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
    AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
    Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
    Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
    Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
    J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
    Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
    AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.
    Alberti N; Frulio N; Bioulac-Sage P; Laumonier H; Balabaud C; Perez JT; Teixeira FR; Harbonnier N; Trillaud H
    Diagn Interv Imaging; 2014 Jan; 95(1):77-83. PubMed ID: 24139183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic contrast-enhanced MR imaging and digital subtraction angiography manifestation of hepatic focal nodular hyperplasia].
    Zhou JX; Li Y; Hong GB; Luo JH; Chen YT; Xu LF; Liang BL
    Ai Zheng; 2008 Nov; 27(11):1186-9. PubMed ID: 19000451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation.
    Ferlicot S; Kobeiter H; Tran Van Nhieu J; Cherqui D; Dhumeaux D; Mathieu D; Zafrani ES
    AJR Am J Roentgenol; 2004 May; 182(5):1227-31. PubMed ID: 15100124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases.
    Attal P; Vilgrain V; Brancatelli G; Paradis V; Terris B; Belghiti J; Taouli B; Menu Y
    Radiology; 2003 Aug; 228(2):465-72. PubMed ID: 12819340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fatty liver background on contrast-enhanced ultrasonographic appearance of focal nodular hyperplasia.
    Lin LW; Yang JJ; Lin XY; Xue ES; He YM; Gao SD; Yang L; Yu LY
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):610-5. PubMed ID: 18086627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
    Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
    J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
    Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
    Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI.
    Furlan A; Brancatelli G; Dioguardi Burgio M; Grazioli L; Lee JM; Murmura E; Lucidarme O; Strauss C; Rode A; Ronot M; Vilgrain V
    AJR Am J Roentgenol; 2018 Apr; 210(4):775-779. PubMed ID: 29323545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
    Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
    BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological features of focal nodular hyperplasia of the liver in children.
    Cheon JE; Kim WS; Kim IO; Jang JJ; Seo JK; Yeon KM
    Pediatr Radiol; 1998 Nov; 28(11):878-83. PubMed ID: 9799323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Typical and atypical features of focal nodular hyperplasia of the liver on helical CT images].
    Zheng L; Wu PH; Shen JX; Mo YX; Xie CM; Ruan CM; Li L
    Ai Zheng; 2006 Jul; 25(7):861-5. PubMed ID: 16831278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases].
    Li AJ; Zhou WP; Wu MC
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):321-3. PubMed ID: 16635391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.